Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registryIbrahim El‐Battrawy, İbrahim Akın, Barbara Gianesin et al.|Journal of Cellular and Molecular Medicine|2022Cited by 10
Efficacy of mitapivat in patients with transfusion-dependent alpha-thalassemia: Subgroup analysis from the ENERGIZE-T trialAshutosh Lal, Vip Viprakasit, Andreas Glenthøj et al.|Blood|2025Cited by 2